The presence of autoantibodies as a potential prognostic biomarker for breast cancer.

The presence of autoantibodies is closely associated with the occurrence and development of cancer. Autoantibodies can be used as biomarkers for early breast cancer diagnosis. However, the relationship between autoantibodies and the prognosis of breast cancer patients remains elusive.

Corrigendum: The presence of autoantibodies is associated with improved overall survival in lung cancer patients.

[This corrects the article DOI: 10.3389/fonc.2023.

The presence of autoantibodies is associated with improved overall survival in lung cancer patients.

Objective: Autoantibodies have been reported to be associated with cancers. As a biomarker, autoantibodies have been widely used in the early screening of lung cancer. However, the correlation between autoantibodies and the prognosis of lung cancer patients is poorly understood, especially in the Asian population.